Feb 9 (Reuters) - Phathom Pharmaceuticals Inc PHAT.O :
* PHATHOM PHARMACEUTICALS PROVIDES REGULATORY UPDATES
* PHATHOM PHARMA - ANNOUNCED REGULATORY UPDATES FOR ITS
APPROVED
PRODUCTS, VOQUEZNA TRIPLE PAK AND VOQUEZNA DUAL PAK, & ITS
PENDING NDA FOR VONOPRAZAN
* PHATHOM PHARMA - HAS RECEIVED COMPLETE RESPONSE LETTERS
FROM FDA
RELATING TO EROSIVE ESOPHAGITIS NDA AND H. PYLORI POST APPROVAL
SUPPLEMENT
* PHATHOM-EXPECTS TO MEET FDA IN Q1 TO DISCUSS RESUBMISSION
PLAN,TIMELINE THAT CO BELIEVES WILL LEAD TO APPROVAL,LAUNCH OF
PRODUCTS CONTAINING VONOPRAZAN
Source text for Eikon: ID:nGNX3x696C
Further company coverage: PHAT.O
((Reuters.Briefs@thomsonreuters.com;))